Revalia Bio, Inc.

1 known investors

Revalia uses AI to transform donated human organs and tissues into biological datasets and clinical insights for drug and device development. The company provides end-to-end infrastructure for generating, integrating, and delivering human biology data at scale to accelerate medical research and reduce reliance on approximate biological models.

AI & Machine LearningBiotechDeep Tech